GlassScriptPhysician profile
Brittany N Wright
NPI 1104278746
$10,440.69
in general payments reported to CMS, 2019-2025
60 companies · $2,180 in 2025
The $2,180 reported for 2025 was more than what 96% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,725 · 2022: $2,680 · 2023: $1,458 · 2024: $1,397 · 2025: $2,180.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,547 · Education: $489.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,547.32 |
| Education | $488.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $1,508.35 | 2021-2025 | Tecvayli, Darzalex, Erleada |
| Incyte Corporation | $694.55 | 2021-2025 | Jakafi, Niktimvo, Monjuvi |
| Astrazeneca Pharmaceuticals LP | $613.28 | 2021-2025 | Calquence |
| Merck Sharp & Dohme LLC | $575.87 | 2021-2025 | Prevymis, Keytruda, Lynparza |
| Astellas Pharma US INC | $573.81 | 2021-2025 | Xospata |
| Genentech USA, INC. | $460.00 | 2021-2025 | Lunsumio, Columvi, Polivy |
| Celgene Corporation | $433.58 | 2021-2025 | Abecma, Onureg, Reblozyl |
| Seagen INC. | $427.25 | 2021-2025 | Adcetris |
| Genzyme Corporation | $415.93 | 2021-2024 | |
| Novartis Pharmaceuticals Corporation | $385.92 | 2022-2025 | |
| Pharmacyclics LLC, An Abbvie Company | $288.70 | 2021-2023 | Imbruvica |
| Takeda Pharmaceuticals U.S.A., INC. | $283.80 | 2021-2025 | Ninlaro, Livtencity |
| Amgen INC. | $278.21 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $246.44 | 2021-2023 | Opdualag, Eliquis, Pomalyst |
| Pfizer INC. | $237.37 | 2021-2025 |
Show all 60 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brittany Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.